))
Episode 14. MRD in Multiple Myeloma
Manage episode 353523172 series 3369804
Innehåll tillhandahållet av Rajshekhar Chakraborty and Ashwin Kishtagari, Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff. Allt poddinnehåll inklusive avsnitt, grafik och podcastbeskrivningar laddas upp och tillhandahålls direkt av Rajshekhar Chakraborty and Ashwin Kishtagari, Rajshekhar Chakraborty, Ashwin Kishtagari, and Edward Cliff eller deras podcastplattformspartner. Om du tror att någon använder ditt upphovsrättsskyddade verk utan din tillåtelse kan du följa processen som beskrivs här https://sv.player.fm/legal.
1. Excellent paper on harmonization of performing and reporting MRD in multiple myeloma:
https://www.nature.com/articles/s41375-020-01012-4
2. Does CR really matter in the era of MRD? Landmark paper from the Spanish Group:
https://pubmed.ncbi.nlm.nih.gov/35560160/
3. Meta-analysis showing individual-level prognostic impact of MRD on long-term outcomes in multiple myeloma:
https://pubmed.ncbi.nlm.nih.gov/33284948/
4. MASTER Trial-The first trial testing MRD-adapted treatment strategy in multiple myeloma :
https://pubmed.ncbi.nlm.nih.gov/34898239/
47 episoder
Dela
